Wordt geladen...

New emerging targets in cancer immunotherapy: the role of LAG3

The success of immunotherapy in many disease entities is limited to a specific subpopulation of patients. To overcome this problem, dual blockade treatments mainly against cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and programmed cell death receptor (ligand) 1 (PD-(L)1) axis were developed....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:ESMO Open
Hoofdauteurs: Puhr, Hannah Christina, Ilhan-Mutlu, Aysegül
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 2019
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6555869/
https://ncbi.nlm.nih.gov/pubmed/31231559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000482
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!